11 - Drugs and the Heart Flashcards

1
Q

What cells constitute the primary pacemaker site within the heart and how are they characterised?

A

Cells of the Sinoatrial Node (SAN)

  • characterised as having no true resting potential
  • instead they generate regular, spontaneous action potentials
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is the depolarising current carried into SAN cells?

A

Unlike non-pacemaker action potentials in the heart, and most other cells that elicit action potentials (e.g., nerve cells, muscle cells), the depolarizing current is carried Into the SAN cells primarily by relatively slow Ca2+ currents instead of by fast Na+ currents.

There are no fast Na+ channels and currents operating in SAN cells

DEPOLARISATION IS NOT DRIVEN BY SODIUM AS IT NORMALLY IS IN THE BODY, BUT BY CALCIUM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What parts of the heart control heart rate?

A

Sinoatrial Node (SAN)

Atrioventricular Node (AVN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain the mechanism behind depolarisation in the SAN

A
  • Several channels are important in regulating the sinoatrial action potential
  • if = funny channel
    • Full Name: Hyperpolarisation-activated cyclic nucleotide-gated channel (HCN channels)
    • This channel is responsible for allowing the action potential to propagate
    • It is a sodium channel
  • If opens at the most negative potential
  • You initially sodium influx then a certain amount of depolarisation and then the calcium channels open
  • The calcium channels come in TWO forms:
    • T type = transient
    • L type = long lasting
  • The opening of the calcium channels increases the depolarisation
  • Potassium channels opening is responsible for repolarisation
  • Beta adrenoceptors are coupled with adenylate cyclase and cause an increase in cAMP
  • This is important in opening the if channel
  • So the sympathetic nervous system is responsible for causing this increase in cAMP and it also has a positive effect on calcium entry
  • The sympathetic nervous system increases heart rate via its positive effect on the if channel
  • The parasympathetic nervous system is negatively coupled with adenylate cyclase and promotes the opening of potassium channels and prolongs repolarisation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Where is the major store of calcium within the myocytes?

A

Sarcoplasmic Reticulum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the two signalling pathways used by the heart to elevate levels of intracellular second messengers?

A

The heart has two signalling pathways that are involved in elevating the levels of intracellular second messengers:

  • cAMP
  • Ca2+
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What happens in the heart in response to depolarisation?

A
  • Calcium enters the cells thrrough calcium channels in the plasma [dihydropyridine receptors (DHPR)]
  • This calcium then goes to bind to calcium release channel [ryanodine receptors (RyR)] to stimulates calcium release from the sarcoplasmic reticulum
  • After stimulating contraction by binding to troponin in the thin filament, the calcium is the removed from the myoplasm by the Plasma Membrane Calcium ATPase (PMCA) or Na+-Ca2+ exchangers, noth of which are found in the plasma membrane
  • The calcium can also be taken back up into the sarcoplasmic reticulum by sarco-enodplasmic reticulum calcium ATPase (SERCA2a)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is SERCA2a responsible for?

A

The removal of >70% of myoplasmic Ca2+ in humans

As a result, SERCA2a determines both:

  • the rate of Ca2+ removal (and consequently the rate of cardiac muscle relaxation)
  • the size of Ca2+ store (which affects cardiac contracility in the subsequent beat)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What regulates the activity of SERCA2a?

A

Its activity is regulated by its interaction with phospholamban (PLN) which is a target for phosphorylation by protein kinase A via the second signalling pathway (adrenergic receptor pathway)

  • In its dephosphorylated form, PLN is an inhibitor of SERCA2a
  • When phosphorylated by PKA, PLN dissociates from SERCA2a activating the Ca2+ pump

As a result, the rate of cardiac relaxation is increased and, on subsequent beats, contractility is increased in proportion to the elevation in the size of the SR Ca2+ store and the resulting increase in Ca2+ release from the SR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is PLN dephosphorylated?

A

PLN is dephosphorylated by a protein phosphatase (PP1) which terminates the stimulation phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How much of the calcium needed for contraction comes from influx?

A

20-30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why is it relatively easy for myocardial oxygen demand to exceed supply?

A

The heart isn’t particularly well perfused compared to the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What vessels deliver oxygen and nutrients to the heart muscle?

A

Coronary vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does oxygen delivery to the heart depend on?

A
  • Heart Rate
  • Preload
  • Afterload
  • Contractility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are preload and afterload linked to?

A

PRELOAD

  • Linked to venous return
  • Increased venous return = increased cardiac contractility

AFTERLOAD

  • Increased afterload = increased TPR
  • Heart has to work harder against increased TPR

These are all associated with increased myocardial work and myocardial oxygen demand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What can increase force of contraction?

A

Myocyte contraction = primary determinant of myocardial oxygen demand

↑ H.R. = more contractions;

↑ afterload or contractility = greater force of contraction

↑ preload = small ↑ in force of contraction

( 100% ↑ ventricular volume would only ↑ F.O.C. by 25%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is preload?

A

Preload is the end diastolic volume that stretches the right or left ventricle of the heart to its greatest dimensions under variable physiologic demand.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is afterload?

A

Afterload is the pressure against which the heart must work to eject blood during systole.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How can certain drugs influence heart rate?

A

Beta-Blockers

  • if and ica
  • Blocks the amount of cAMP being produced so you reduce the activation of the if and calcium channels
  • This, in turn, means that you reduce the ability of the SA node to depolarise
  • Prolong start to depolarisation
  • Flatter initial curve

Calcium Channel Antagonists

  • ica
  • Blocks calcium current

Ivabradine

  • if
  • Blocks funny current

End result of all these drugs result in a reduction in heart rate

20
Q

How can certain drugs influence cardiac contractility?

A

Beta-Blockers

  • block beta1-receptors
  • less cAMP produced
  • less downstream signalling
  • reduces cardiac contracility
  • hence reduce cardiac work

Calcium Channel Antagonists

  • block calcium channels in the plasma membrane
  • reduced influx of external calcium
  • also reduced release of calcium from the SR
  • reduce cardiac contractility
  • different to beta-blockers as these directly block L-type channels
21
Q

What are the different classes of Calcium Antagonists (Calcium-Channel Blockers)?

A

TWO CLASSES

Rate-Slowing (Cardiac and Smooth Muscle Actions)

  • Phenylalkylamines (e.g. Verapamil)
  • Benzothiazepines (e.g. Diltiazem)
  • Reduce heart rate and cause vasodilation

Non Rate-Slowing (Smooth Muscle Actions)

  • Dihydropyridines (e.g. Amlopidine)
  • More potent than other class
  • Don’t affect the heart
  • But profound vasodilation can cause reflex tachycardia
22
Q

What drugs can influence myocardial oxygen/supply demand?

A

Two types of drug can affect myocardial oxygen supply/demand

  • Organic Nitrates
  • Potassium Channel Openers
23
Q

How can certain drugs influence myocardial oxygen/supply demand?

A

ORGANIC NITRATES

  • Substrates for NO production
  • Enter they endothelial cells and promote NO production
  • NO diffuses into vascular smooth muscle
  • Causes smooth muscle relaxation

POTASSIUM CHANNEL OPENERS

  • Promote potassium efflux
  • So they hyperpolarise the smooth muscle
  • Reduces its ability to contract
  • Smooth muscle relaxation ensues

THEREFORE, BOTH TYPES OF DRUGS PROMOTE SMOOTH MUSCLE RELAXATION AND HENCE, VASODILATION

  • Vasodilation reduces TPR
  • Hence reduces afterload
  • This means that the heart has to work less against the resistance
  • The drugs also cause venodilation which reduces venous return to the heart
  • Hence reduces preload and contractility
  • This reduction is afterload and preload causes a decrease in myocardial oxygen demand
  • Improves balance between supply and demand, meaning they are potentially good treatments for angina
24
Q

Typically, when are organic nitrates clinically used?

A

Angina

  • when there is profound atherosclerosis reducing blood flow to the heart
  • give before the patient exercises because it dilates coronary vessels so blood flow is improved
25
Q

What is the difference in administration of potassium-channel openers and organic nitrates for angina?

A

Organic Nitrates

  • short-acting
  • used for immediate vasodilation
  • symptomatic treatment

Potassium Channel Openers

  • not used that much
  • used if patient is intolerant to other drugs
26
Q

Why can beta blockers have side-effects?

A

Due to actions on beta1 (and sometimes beta2 receptors due to only partial-selectivity)

Despite being cardioselective, few drugs are totally selective

27
Q

Why must caution be taken when giving beta blockers to a patient with cardiac failure?

A

Beta2 receptor blockade can cause:

WORSENED HEART FAILURE

  • Cardiac Output reduction
  • Reduce vasodilation
  • Increased vascular resistance (TPR)
  • Worsens heart failure

BRADYCARDIA

  • Heart block
  • Due to less conduction through AV node

ALTHOUGH, PINDOLOL WILL HAVE SOME BETA2 STIMULATING EFFECTS DUE TO ISA. CARVEDILOL WILL HAVE ALPHA1 BLOCKING EFFECTS WHICH CAN DECREASE TPR AND ALLEVIATE THIS PROBLEM.

28
Q

What are the main side-effects of beta blockers?

A

Worsening of cardiac failure

  • Cardiac Output (CO) reduction

Bradycardia

  • Heart block due to less conduction through AV node

Brochoconstriction

  • Blockade of beta2 receptors in airways
  • Contraindicated in asthmatics

Hypoglycaemia

  • in diabetics on insulin
  • decreased glycogenolysis
  • gluconeogenesis
  • Liver can’t release glucose
  • Contraindicated in diabetics

Cold extremities and worsening of peripheral arterial disease

  • blockade of beta2 receptors in skeletal muscle vessels
  • loss of beta2 receptor mediated cutaneous vasodilation in extremities
  • Fatigue*
  • Impotence (sexual dysfunction)*
  • Depression*
  • CNS effects (lipophilic agents)*
  • * Those in italics are not clinically relevant as of yet due to RCTs questioning their validity*
29
Q

In what patients are beta blockers contraindicated?

A

Asthmatics

Diabetics

30
Q

What are the side-effects of calcium channel blockers?

A

CCBs that target the heart have similar effects to beta blockers

With any drug that causes profound vasodilation, you need to think about fluid accumulation

More leakage through capillaries into tissues

Worse the further you are from the heart due to gravity

RATE-LIMITING (e.g. Verapamil)

  • Bradycardia
    • Due to AV Block
    • Ca2+ channel block
  • Constipation
    • Gut Ca2+ channels
    • 25% of patients
    • Decreased motility/movement of food through GI tract

NON RATE-LIMITING (e.g. Dihydropyridines)

Vasodilation/Reflex Adrenergic Activation

  • Ankle Oedema
    • Due to profound vasodilation
    • More pressure on capillary vessels
    • Lots of fluid leakage
  • Headache/Flushing
    • Vasodilation
  • Palpitations
31
Q

How many people in the UK are affected by abnormalities of cardiac rhythm?

A

Abnormalities of cardiac rhythm (arrhythmias/dysrhythmias) affect around 700,000 people in UK.

32
Q

What are the aims of treatment for people with cardiac rhythm abnormalities and what does treatment typically involve?

A
  • Reduce sudden death
  • Prevent stroke
  • Alleviate symptoms

Management is complex and is usually undertaken by specialists. May involve:

  • cardioversion
  • pacemakers
  • catheter ablation therapy
  • implantable defibrillators
  • drug therapy
33
Q

What is a simple classification system used for arrhythmias?

A

A simple classification of arrhythmias is based on its site of origin:

  • Supraventricular Arrhythmias (amiodarone and verapamil)
  • Ventricular Arrhythmias (flecainide and lidocaine)
  • Complex (supraventricular and ventricular arrhythmias - e.g. disopyramide)
34
Q

What is the Vaughan Williams Classification system?

A

A classification system for anti-arrhythmic drugs

Vaughan Williams classification is of limited clinical significance

CLASS I

  • Sodium channel blockade

CLASS II

  • Beta adrenergic blockade

CLASS III

  • Prolongation of repolarisation (‘membrane stabilisation’, mainly due to potassium channel blockade)

CLASS IV

  • Calcium channel blockade
35
Q

What is adenosine used for in the context arrythmia?

A

It is a selected anti-arrythmic

Used intravenously to terminate supraventricular tachyarrhythmias(SVT)

Its actions are short-lived (20-30s) and it is consequently safer than verapamil.

The action of adenosine in cardiac tissue is:

  • Adenosine binds to type 1 (A1) adenosine receptors in the cardiac muscle and vascular smooth muscle
  • These receptors are coupled to Gi proteins
  • Activativtion of the Gi protein decreases cAMP
  • This means that there is less cAMP within the nodal tissue and so it impacts on the depolarisation within the AV node
  • Less cAMP inhibits L-type calcium channels and therefore calcium entry into the cell. (Adenosine receptors are negatively coupled with adenylate cyclase)
  • Activation of this pathway opens potassium channels, which hyperpolarizes the cell.
  • So if you have tachyarrhythmia, you can slow the heart down and restore normal rhythm so there is more efficiency in the movement of blood from the atria to the ventricles
  • In cardiac pacemaker cells located in the sinoatrial node, adenosine acting through A1 receptors inhibits the pacemaker current (If), which decreases the slope of phase 4 of the pacemaker action potentialthereby decreasing its spontaneous firing rate (negative chronotropy).
36
Q

What does adenosine normally do in coronary vascular smooth muscle?

A
  • In coronary vascular smooth muscle, adenosine binds to adenosine type 2A (A2A) receptors, which are coupled to the Gs-protein.
  • Activation of this G-protein stimulates adenylyl cyclase, increases cAMP and causes protein kinase activation.
  • This stimulates KATP channels, which hyperpolarizes the smooth muscle, causing relaxation.
  • Increased cAMP also causes smooth muscle relaxation by inhibiting myosin light chain kinase, which leads to decreased myosin phosphorylation and a decrease in contractile force.
  • There is also evidence that adenosine inhibits calcium entry into the cell through L-type calcium channels.
37
Q

What is Verapamil used for in the context of arrythmia?

A

Used for reduction of ventricular responsiveness to atrial arrythmias

It depresses SA automaticity and subsequent AV node conduction

  • This mainly targets the L-type calcium channels
  • This slows down the ability of the nodal tissue to depolarise
  • If you have rapid excessive depolarisations, as in tachyarrhythmias, you want to reduce that effect
  • CCBs block the membrane calcium channels so there is less calcium entry so the speed with which tissue can depolarise is reduced

This restores some normal contraction

38
Q

What is Amiodarone used for in the context of arrythmia?

A

Used for supraventricular and ventricular tachyarrhythmias (often due to reentry)

Work via complex action probably involving multiple ion channel blocking

  • This prolongs repolarisation
  • It has a complex mechanism of action that involved multiple ion channel blockade but its main action seems to be through potassium channel blockade
  • By prolonging repolarisation, you’re prolonging the time during which the heart can NOT depolarise, thus restoring normal rhythm
  • By prolonging repolarisation, you’re trying to reduce re-entry
  • With cardiac tissue, as the action potential is propagated through the tissue you can have damaged bits of tissue where the action potential struggles to pass through
  • IMPORTANT POINT: THIS IS USUALLY UNIDIRECTIONAL
  • The action potential will struggle to go one way but then it is fine to go back in the opposite direction
  • In the bottom left diagram, the action potential (red) passes around the bottom left corner and because the damaged tissue (shaded blue) has not been depolarised by the action potential on the way down from the top, the action potential can pass back up the tissue and you get cyclical depolarisation
  • This is the basis of arrhythmias
  • By prolonging repolarisation you can reduce the likelihood of re-entry happening
39
Q

What are the adverse effects of amiodarone?

A
  • Amiodarone accumulates in the body (t½ 10 - 100days)
  • Has a number of important adverse effects including:
    • photosensitive skin rashes
    • hypo- or hyper-thyroidism
    • pulmonary fibrosis
40
Q

How can rentry precipitate ventricular and atrial tachyarrhythmias?

A

In normal tissue (top panel of figure), if a single Purkinje fiber forms two branches (1 & 2), the action potential will travel down each branch.

An electrode (*) in a side branch off of branch 1 would record single, normal action potentials as they are conducted down branch 1 and into the side branch.

If branches 1 & 2 are connected together by a common, connecting pathway (branch 3), the action potentials that travel into branch 3 will cancel each other out

Reentry (bottom panel) can occur if branch 2, for example, has a unidirectional block.

  • In such a block, impulses can travel retrograde (from branch 3 into branch 2) but not orthograde.
  • When this condition exists, an action potential will travel down the branch 1, into the common distal path (branch 3), and then travel retrograde through the unidirectional block in branch 2 (blue line).
  • Within the block (gray area), the conduction velocity is reduced because of depolarization.
  • When the action potential exits the block, if it finds the tissue excitable, then the action potential will continue by traveling down (i.e., reenter) the branch 1.
  • If the action potential exits the block in branch 2 and finds the tissue unexcitable (i.e., within its effective refractory period), then the action potential will die.

Therefore, timing is critical in that the action potential exiting the block must find excitable tissue in order for that action potential to continue to propagate.

  • If it can re-excite the tissue, a circular (counterclockwisein this case) pathway of high frequency impulses (i.e., a tachyarrhythmia) will become the source of action potentials that spread throughout a region of the heart (e.g., ventricle) or the entire heart.

Local sites of reentrymay involve only a small region within the ventricle or atrium and can precipitate ventricular or atrial tachyarrhythmias, respectively.

Because both timing and refractory state of the tissue are important for reentry to occur, alterations in timing (related to conduction velocity) and refractoriness (related to effective refractory period) can either precipitate reentryor abolish reentry.

For this reason, changes in autonomic nerve function can significantly affect reentrymechanisms, either precipitating or terminating reentry. Many antiarrhythmic drugsalter effective refractory period or conduction velocity, and thereby affect reentrymechanisms (hopefully abolish).

41
Q

What effect does digoxin (cardiac glycoside) have on inotropy?

A

Inhibits sodium-potassium ATPase

  • Sodium is less well exported out of the cell
  • More sodium retained in cell
  • Sodium calcium exchanger works more effectively
  • More calcium builds in cardiomyocyte
  • Increases inotropy

[Inhibition of Na-K-ATPase (Na/K pump). This results in increased intracellular Ca2+via effects on Na+/Ca2+exchange → positive inotropic effect]

42
Q

What are the adverse effects of digoxin (cardiac glycoside)?

A
  • dysrhythmias (e.g. AV conduction block, ectopic pacemaker activity)
  • Note: Hypokalaemia (usually a consequence of diuretic use) lowers the threshold for digoxin toxicity because potassium and digoxin compete for the same binding site
    • When it binds, it prevents sodium potaasium exchnage
    • At low blood potassium, digoxin has easier access to block the receptor so has a much more powerful effect
43
Q

What is digoxin (cardiac glycoside) used for?

A
  • Atrial fibrillation and flutter lead to a rapid ventricular rate that can impair ventricular filling (due to decreased filling time) and reduce cardiac output.
  • Digoxin via vagal stimulation reduces the conduction of electrical impulses within the AV node.
  • Does this via central vagal stimulation causing increased refractory period and reduced rate of conduction through the AV nod
  • Fewer impulses reach the ventricles and ventricular rate falls.
44
Q

What is the mechanism of action of digoxin (cardiac glycoside)?

A
  • Cardiac glycosides inhibit Na+/K+ pump
  • It blocks the channel and reduces the ability for sodium and potassium to move in and out of the cell
  • If you block the sodium-potassium exchange the sodium builds up inside the cell because you remove the ability to efflux the sodium
  • Another mechanism of removing sodium is via the Na+/Ca2+ exchanger - this leads to a build up of calcium within the cell
  • This means that digoxin slows down the heart and makes it contract more effectively
  • The protein works by sodium binding to the intracellular component of the channel and potassium binding to the extracellular component, then the protein flip flops
  • Digoxin accesses the pump from outside the cell (from the blood) - as it is on the outside, the digoxin interferes with the potassium binding site
  • If you’re HYPOKALAEMIC then there is less competition between the potassium and digoxin so the digoxin has a far more powerful effect on this protein and that’s where the toxicity comes from
  • So when giving digoxin, you need to know the plasma potassium levels to adjust the dose
  • Digoxin also has an effect on vagal stimulation
  • It stimulates the parasympathetic innervation of the heart so it slows the heart rate via this route as well
45
Q

What are cardiac inotropes and what are they used for?

A

Agents that increase the force of cardiac contraction are used to treat acute heart failure in some situations (e.g. after cardiac surgery or in cardiogenic and septic shock)

Dobutamine is a beta-1 agonist that stimulates cardiac contraction without a major effect on heart rate

If you’re worried that the heart is going to fail in an acute setting, dobutamine is a good drug to use

Phosphodiesterase inhibitors, such as milrinone, have inotropic effects by inhibiting the breakdown of cAMP in cardiac myocytes

But despite increasing cardiac contractile function, so far all inotropes have reducedsurvival in chronic heart failure